BLRX BioLineRx Presents Preclinical Data at ASCO-SITC Showing BL-8040 Prolongs Survival by Mediating Tumor Infiltration of Antigen-Specific T-cell https://finance.yahoo.com/news/biolinerx-presents-preclinical-data-asco-130000549.html